查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889411

数位迷幻疗法市场预测至2032年：按疗法类型、技术、应用、最终用户和地区分類的全球分析

Digital Psychedelic-Therapy Market Forecasts to 2032 - Global Analysis By Therapy Type, Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球数位迷幻疗法市场价值将达到 15 亿美元，到 2032 年将达到 86 亿美元，在预测期内的复合年增长率为 28%。

数位迷幻疗法是指一种身临其境型治疗平台，它结合了虚拟实境（VR）、神经回馈和引导式数位环境，以安全的方式模拟迷幻体验。这些系统利用包括视觉、听觉和触觉回馈在内的多感官输入，诱导意识状态的改变，从而促进心理復原。人工智慧驱动的监控系统确保患者安全，同时根据治疗目标（例如缓解焦虑、忧郁和创伤）量身定制体验。与化学迷幻药不同，数位疗法提供可控且可重复的疗程，透过科技增强的意识探索，为心理健康治疗开闢了新的途径。

根据 MAPS 公益公司的一项调查，68% 的 PTSD 临床试验患者表示，他们更喜欢数位化辅助治疗，因为在熟悉的家庭环境中治疗能带来舒适感和掌控感。

人们对数位疗法的兴趣日益浓厚

市场成长的驱动力在于人们对数位心理健康解决方案日益增长的兴趣，尤其是模拟迷幻体验的身临其境型疗法。由于传统疗法在扩充性和可及性方面面临挑战，数位平台提供了个人化、可扩展的替代方案。人工智慧、虚拟实境和神经回馈技术的进步，为情绪处理和创伤疗癒创造了安全可控的环境。临床研究、公众舆论的转变以及对非药物心理健康疗法的需求，都支持了这种日益增长的兴趣。

对迷幻剂内容有严格的规定

对迷幻药相关内容的监管限制构成重大障碍。儘管这些平台是数位模拟平台，但由于与管制药物相关，许多平台仍受到严格审查。内容审核、授权和心理健康标准合规性因地区而异，限制了其全球扩充性。这些法规影响应用商店、临床应用和研究经费。开发者必须谨慎应对复杂的法律体制，以确保合乎伦理的使用并避免误导，这减缓了数位迷幻疗法的普及和创新。

虚拟医疗环境的出现

创造身临其境型虚拟治疗环境，模拟迷幻剂带来的内省效果，蕴藏着巨大的机会。这些平台结合了引导式疗程、情绪感知人工智慧和神经回馈，提供无需药物的变革性体验。它们吸引着那些寻求安全便捷的创伤復原、焦虑和忧郁症替代方案的用户。与穿戴式装置和个人化虚拟化身的整合进一步提升了使用者参与度。随着心理健康技术的不断发展，这些环境有望重新定义治疗模式，并推动市场扩张。

与心理模拟相关的伦理风险

模拟意识状态改变的市场面临相关的伦理风险。这些风险包括情绪过度刺激、心理依赖、以及在非临床环境中的滥用。如果没有适当的指导，使用者可能会感到痛苦或误解治疗内容。此外，关于情绪分析的资料隐私和知情同意也引发了伦理问题。确保负责任的设计、临床监督和透明的使用者教育对于降低这些风险并维护使用者对数位迷幻疗法平台的信任至关重要。

新冠疫情的影响：

新冠疫情加速了人们对远距心理健康解决方案的需求，并提升了人们对数位迷幻疗法的兴趣。封锁措施和日益加剧的焦虑情绪，使得人们迫切需要便捷、沉浸式的介入手段。临床试验虽有所延误，但消费者接受度却呈现爆炸性成长。疫情后的復苏阶段，人们对专注于提升心理韧性、情绪调节和创伤疗癒的虚拟健康平台投入了更多资金。疫情验证了数位疗法在主流医疗保健中将发挥的作用，并将受迷幻体验启发的模拟疗法确立为一种可行的长期心理健康支持工具。

预计在预测期内，引导式虚拟迷幻体验环节将占据最大的市场份额。

由于其结构化的治疗师主导模式，预计在预测期内，引导式虚拟迷幻体验疗法将占据最大的市场份额。这些疗法利用虚拟实境技术、音景和人工智慧驱动的提示，模拟内省之旅，提供情绪释放和认知重建。其受欢迎程度归功于其可控的治疗方式、较低的风险以及对创伤后压力症候群（PTSD）、焦虑症和成瘾等多种情况的适应性。与临床工作流程的整合以及使用者信任度的提高，使得该领域得到最广泛的应用，巩固了其作为市场收入最大贡献者的地位。

预计在预测期内，VR/XR身临其境型引擎细分市场将实现最高的复合年增长率。

在空间运算和情绪模拟技术的快速发展推动下，VR/XR身临其境型引擎领域预计将在预测期内呈现最高的成长率。这些引擎为数位迷幻疗法的核心体验提供动力，打造逼真且反应迅速的环境。透过扩充性到行动装置、头戴式装置和云端平台，其可及性正在不断提升。随着硬体成本的下降和内容库的不断扩充，身临其境型引擎正成为治疗创新的核心组成部分，吸引投资，并推动其在临床和消费市场的应用。

占比最大的地区：

由于心理健康意识的不断提高、技术基础设施的不断改进以及政府的支持政策，亚太地区预计将在预测期内保持最大的市场份额。中国、日本和韩国等国家正在投资数位健康平台和身临其境型技术。文化上对替代疗法的接受度以及行动互联网的高普及率也促进了这些技术的进一步应用。亚太地区在数位迷幻疗法的应用和创新方面主导作用，区域内的Start-Ups公司和学术机构正在积极开发在地化内容。

复合年增长率最高的地区：

在预测期内，北美预计将实现最高的复合年增长率，这主要得益于强劲的研发投入、早期应用以及有利的法规环境。美国和加拿大拥有许多Start-Ups、临床试验和学术研究机构，致力于开发受迷幻药启发的数位疗法。与保险系统、心理健康应用程式和远端医疗平台的整合正在推动成长。社会对迷幻药科学的接受度以及对身临其境型技术的投资，使北美成为成长最快的地区，并推动了该市场的创新和全球影响力。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要参与者（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，对主要国家的市场规模和复合年增长率进行估算和预测（註：可行性需确认）。
  • 竞争基准化分析
    • 根据主要参与者的产品系列、地理覆盖范围和策略联盟基准化分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球数位迷幻疗法市场（依疗法类型划分）

  • 引导式虚拟迷幻体验
  • 人工智慧辅助认知重置疗法
  • 身临其境型虚拟实境情绪处理疗法
  • 综合迷幻健康平台
  • 神经回馈辅助疗法
  • 数位售后服务与整合计划

6. 全球数位迷幻疗法市场（依技术划分）

  • VR与XR身临其境型引擎
  • 情绪识别人工智慧系统
  • 神经影像学和脑电图分析
  • 迷幻模拟演算法
  • 行动感测器集成
  • 人工智慧驱动的数位教练

7. 全球数位迷幻疗法市场（按应用划分）

  • 心理健康治疗
  • 忧郁症与焦虑症管理
  • 创伤后压力症候群与创伤治疗
  • 成瘾治疗
  • 其他用途

8. 全球数位迷幻疗法市场（以最终用户划分）

  • 精神病诊所
  • 数位疗法公司
  • 研究所
  • 企业健康服务提供者
  • 家庭治疗用户

9. 全球数位迷幻疗法市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Compass Pathways
  • MindMed
  • Atai Life Sciences
  • Cybin
  • Johnson &Johnson
  • Novartis
  • Field Trip Health
  • Beckley Psytech
  • Small Pharma
  • NeuroRX
  • Otsuka Pharmaceutical
  • Lundbeck
  • Medtronic
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers
  • Pear Therapeutics
  • Teladoc Health
Product Code: SMRC32780

According to Stratistics MRC, the Global Digital Psychedelic-Therapy Market is accounted for $1.5 billion in 2025 and is expected to reach $8.6 billion by 2032 growing at a CAGR of 28% during the forecast period. Digital Psychedelic-Therapy refers to immersive therapeutic platforms that combine virtual reality, neurofeedback, and guided digital environments to simulate psychedelic experiences safely. These systems use multisensory inputs-visuals, audio, and haptic feedback-to induce altered states of consciousness for psychological healing. AI-driven monitoring ensures patient safety and tailors experiences to therapeutic goals, such as reducing anxiety, depression, or trauma. Unlike chemical psychedelics, digital therapy provides controlled, repeatable sessions, offering a novel approach to mental health treatment through technology-enhanced consciousness exploration.

According to a MAPS public benefit corporation survey, 68% of patients in clinical trials for PTSD reported a preference for digitally-assisted therapy sessions, citing the comfort and control provided by a familiar, home-based environment.

Market Dynamics:

Driver:

Rising interest in digital therapies

The market is propelled by growing interest in digital mental health solutions, especially immersive therapies that simulate psychedelic experiences. As traditional therapy models face scalability and accessibility challenges, digital platforms offer personalized, scalable alternatives. Advances in AI, VR, and neurofeedback are enabling safe, controlled environments for emotional processing and trauma healing. This surge in interest is supported by clinical research, shifting public perception, and demand for non-pharmacological interventions in mental wellness.

Restraint:

Strict controls on psychedelic content

Regulatory restrictions on psychedelic-related content pose a significant restraint. Despite being digital simulations, many platforms face scrutiny due to associations with controlled substances. Content moderation, licensing, and compliance with mental health standards vary across regions, limiting global scalability. These controls affect app stores, clinical deployment, and research funding. Developers must navigate complex legal frameworks to ensure ethical use and avoid misrepresentation, slowing adoption and innovation in digital psychedelic therapy.

Opportunity:

Emergence of virtual therapeutic environments

A major opportunity lies in the creation of immersive virtual therapeutic environments that replicate the introspective effects of psychedelics. These platforms combine guided sessions, emotion-recognition AI, and neurofeedback to deliver transformative experiences without pharmacological agents. They appeal to users seeking safe, accessible alternatives for trauma recovery, anxiety, and depression. Integration with wearables and personalized avatars enhances engagement. As mental health tech evolves, these environments are poised to redefine therapy delivery and expand market reach.

Threat:

Ethical risks around mental simulation

The market faces ethical risks related to simulating altered states of consciousness. Concerns include emotional overstimulation, psychological dependency, and misuse in non-clinical settings. Without proper guidance, users may experience distress or misinterpret therapeutic content. Additionally, data privacy and consent around emotional profiling raise ethical flags. Ensuring responsible design, clinical oversight, and transparent user education is critical to mitigate these risks and maintain trust in digital psychedelic therapy platforms.

Covid-19 Impact:

Covid-19 accelerated demand for remote mental health solutions, boosting interest in digital psychedelic therapy. Lockdowns and rising anxiety levels created urgency for accessible, immersive interventions. While clinical trials slowed, consumer adoption surged. Post-pandemic recovery has seen increased investment in virtual wellness platforms, with emphasis on resilience, emotional regulation, and trauma healing. The pandemic validated digital therapy's role in mainstream healthcare, positioning psychedelic-inspired simulations as a viable tool for long-term mental health support.

The guided virtual psychedelic sessions segment is expected to be the largest during the forecast period

The guided virtual psychedelic sessions segment is expected to account for the largest market share during the forecast period, due to their structured, therapist-led approach. These sessions simulate introspective journeys using VR, soundscapes, and AI-driven prompts, offering emotional release and cognitive reframing. Their popularity stems from controlled delivery, reduced risk, and adaptability across conditions like PTSD, anxiety, and addiction. Integration with clinical workflows and growing user trust make this segment the most widely adopted, securing its position as the largest contributor to market revenue.

The VR & XR immersive engines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the VR & XR immersive engines segment is predicted to witness the highest growth rate, driven by rapid advancements in spatial computing and emotional simulation. These engines power the core experience of digital psychedelic therapy, enabling realistic, responsive environments. Their scalability across mobile, headset, and cloud platforms enhances accessibility. As hardware costs drop and content libraries expand, immersive engines are becoming central to therapeutic innovation, attracting investment and driving adoption in both clinical and consumer markets.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising mental health awareness, expanding tech infrastructure, and supportive government initiatives. Countries like China, Japan, and South Korea are investing in digital wellness platforms and immersive technologies. Cultural openness to alternative therapies and high mobile penetration further support adoption. Regional startups and academic institutions are actively developing localized content, making Asia Pacific a dominant force in digital psychedelic therapy deployment and innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by strong R&D, early adoption, and favorable regulatory shifts. The U.S. and Canada host leading startups, clinical trials, and academic research in psychedelic-inspired digital therapies. Integration with insurance systems, mental health apps, and telehealth platforms accelerates growth. Public acceptance of psychedelic science and investment in immersive tech position North America as the fastest-growing region, driving innovation and global influence in this market.

Key players in the market

Some of the key players in Digital Psychedelic-Therapy Market include Compass Pathways, MindMed, Atai Life Sciences, Cybin, Johnson & Johnson, Novartis, Field Trip Health, Beckley Psytech, Small Pharma, NeuroRX, Otsuka Pharmaceutical, Lundbeck, Medtronic, Philips Healthcare, GE Healthcare, Siemens Healthineers, Pear Therapeutics, and Teladoc Health

Key Developments:

In November 2025, Compass Pathways introduced its immersive digital therapy platform combining guided psychedelic simulations with AI-driven patient monitoring. The system delivers structured therapeutic journeys for depression and anxiety, offering clinicians real-time insights into patient progress.

In October 2025, MindMed launched its next-generation digital psychedelic integration app designed to support patients post-session with adaptive cognitive exercises and mood tracking. The app enhances long-term outcomes by embedding personalized therapeutic content into daily routines.

In September 2025, Atai Life Sciences announced the rollout of its VR-enabled therapeutic environment for clinical trials, enabling controlled psychedelic-inspired experiences. The platform integrates biometric feedback and therapist dashboards, supporting scalable deployment in mental health research and treatment.

Therapy Types Covered:

  • Guided Virtual Psychedelic Sessions
  • AI-Assisted Cognitive Reset Therapy
  • Immersive VR Emotional Processing
  • Integrated Psychedelic Wellness Platforms
  • Neurofeedback-Assisted Therapies
  • Digital Aftercare & Integration Programs

Technologies Covered:

  • VR & XR Immersive Engines
  • Emotion-Recognition AI Systems
  • Neuroimaging & Brainwave Analytics
  • Psychedelic Simulation Algorithms
  • Mobile Sensor Integration
  • AI-Powered Digital Coaches

Applications Covered:

  • Mental Health Therapy
  • Depression & Anxiety Management
  • PTSD & Trauma Therapy
  • Addiction Treatment
  • Other Applications

End Users Covered:

  • Psychiatric Clinics
  • Digital Therapeutics Companies
  • Research Institutions
  • Corporate Wellness Providers
  • Home-Based Therapy Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Psychedelic-Therapy Market, By Therapy Type

  • 5.1 Introduction
  • 5.2 Guided Virtual Psychedelic Sessions
  • 5.3 AI-Assisted Cognitive Reset Therapy
  • 5.4 Immersive VR Emotional Processing
  • 5.5 Integrated Psychedelic Wellness Platforms
  • 5.6 Neurofeedback-Assisted Therapies
  • 5.7 Digital Aftercare & Integration Programs

6 Global Digital Psychedelic-Therapy Market, By Technology

  • 6.1 Introduction
  • 6.2 VR & XR Immersive Engines
  • 6.3 Emotion-Recognition AI Systems
  • 6.4 Neuroimaging & Brainwave Analytics
  • 6.5 Psychedelic Simulation Algorithms
  • 6.6 Mobile Sensor Integration
  • 6.6 AI-Powered Digital Coaches

7 Global Digital Psychedelic-Therapy Market, By Application

  • 7.1 Introduction
  • 7.2 Mental Health Therapy
  • 7.3 Depression & Anxiety Management
  • 7.4 PTSD & Trauma Therapy
  • 7.5 Addiction Treatment
  • 7.6 Other Applications

8 Global Digital Psychedelic-Therapy Market, By End User

  • 8.1 Introduction
  • 8.2 Psychiatric Clinics
  • 8.3 Digital Therapeutics Companies
  • 8.4 Research Institutions
  • 8.5 Corporate Wellness Providers
  • 8.6 Home-Based Therapy Users

9 Global Digital Psychedelic-Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Compass Pathways
  • 11.2 MindMed
  • 11.3 Atai Life Sciences
  • 11.4 Cybin
  • 11.5 Johnson & Johnson
  • 11.6 Novartis
  • 11.7 Field Trip Health
  • 11.8 Beckley Psytech
  • 11.9 Small Pharma
  • 11.10 NeuroRX
  • 11.11 Otsuka Pharmaceutical
  • 11.12 Lundbeck
  • 11.13 Medtronic
  • 11.14 Philips Healthcare
  • 11.15 GE Healthcare
  • 11.16 Siemens Healthineers
  • 11.17 Pear Therapeutics
  • 11.18 Teladoc Health

List of Tables

  • Table 1 Global Digital Psychedelic-Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Psychedelic-Therapy Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 3 Global Digital Psychedelic-Therapy Market Outlook, By Guided Virtual Psychedelic Sessions (2024-2032) ($MN)
  • Table 4 Global Digital Psychedelic-Therapy Market Outlook, By AI-Assisted Cognitive Reset Therapy (2024-2032) ($MN)
  • Table 5 Global Digital Psychedelic-Therapy Market Outlook, By Immersive VR Emotional Processing (2024-2032) ($MN)
  • Table 6 Global Digital Psychedelic-Therapy Market Outlook, By Integrated Psychedelic Wellness Platforms (2024-2032) ($MN)
  • Table 7 Global Digital Psychedelic-Therapy Market Outlook, By Neurofeedback-Assisted Therapies (2024-2032) ($MN)
  • Table 8 Global Digital Psychedelic-Therapy Market Outlook, By Digital Aftercare & Integration Programs (2024-2032) ($MN)
  • Table 9 Global Digital Psychedelic-Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 10 Global Digital Psychedelic-Therapy Market Outlook, By VR & XR Immersive Engines (2024-2032) ($MN)
  • Table 11 Global Digital Psychedelic-Therapy Market Outlook, By Emotion-Recognition AI Systems (2024-2032) ($MN)
  • Table 12 Global Digital Psychedelic-Therapy Market Outlook, By Neuroimaging & Brainwave Analytics (2024-2032) ($MN)
  • Table 13 Global Digital Psychedelic-Therapy Market Outlook, By Psychedelic Simulation Algorithms (2024-2032) ($MN)
  • Table 14 Global Digital Psychedelic-Therapy Market Outlook, By Mobile Sensor Integration (2024-2032) ($MN)
  • Table 15 Global Digital Psychedelic-Therapy Market Outlook, By AI-Powered Digital Coaches (2024-2032) ($MN)
  • Table 16 Global Digital Psychedelic-Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Digital Psychedelic-Therapy Market Outlook, By Mental Health Therapy (2024-2032) ($MN)
  • Table 18 Global Digital Psychedelic-Therapy Market Outlook, By Depression & Anxiety Management (2024-2032) ($MN)
  • Table 19 Global Digital Psychedelic-Therapy Market Outlook, By PTSD & Trauma Therapy (2024-2032) ($MN)
  • Table 20 Global Digital Psychedelic-Therapy Market Outlook, By Addiction Treatment (2024-2032) ($MN)
  • Table 21 Global Digital Psychedelic-Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 22 Global Digital Psychedelic-Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Digital Psychedelic-Therapy Market Outlook, By Psychiatric Clinics (2024-2032) ($MN)
  • Table 24 Global Digital Psychedelic-Therapy Market Outlook, By Digital Therapeutics Companies (2024-2032) ($MN)
  • Table 25 Global Digital Psychedelic-Therapy Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 26 Global Digital Psychedelic-Therapy Market Outlook, By Corporate Wellness Providers (2024-2032) ($MN)
  • Table 27 Global Digital Psychedelic-Therapy Market Outlook, By Home-Based Therapy Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.